img

Global Systemic Sclerosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Systemic Sclerosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Systemic Sclerosis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Systemic Sclerosis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Systemic Sclerosis Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Systemic Sclerosis Drug key manufacturers include Allergan Plc, Angion Biomedica Corp., arGentis Pharmaceuticals, LLC, Bayer AG, BioLineRx, Ltd., BiOrion Technologies B.V., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company and Corbus pharmaceuticals, Inc., etc. Allergan Plc, Angion Biomedica Corp., arGentis Pharmaceuticals, LLC are top 3 players and held % sales share in total in 2022.
Systemic Sclerosis Drug can be divided into ARG-201, Belimumab, BL-1110 and BOT-191, etc. ARG-201 is the mainstream product in the market, accounting for % sales share globally in 2022.
Systemic Sclerosis Drug is widely used in various fields, such as Hospital, Clinic, ASCs and Others, etc. Hospital provides greatest supports to the Systemic Sclerosis Drug industry development. In 2022, global % sales of Systemic Sclerosis Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Systemic Sclerosis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan Plc
Angion Biomedica Corp.
arGentis Pharmaceuticals, LLC
Bayer AG
BioLineRx, Ltd.
BiOrion Technologies B.V.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Corbus pharmaceuticals, Inc.
CSL Limited
Daval International Limited
Digna Biotech, S.L.
F. Hoffmann-La Roche Ltd.
Fibrocell Science, Inc.
GenKyoTex S.A.
GlaxoSmithKline Plc
Segment by Type
ARG-201
Belimumab
BL-1110
BOT-191
C-82
Others

Segment by Application


Hospital
Clinic
ASCs
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Systemic Sclerosis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Systemic Sclerosis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Systemic Sclerosis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Systemic Sclerosis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Systemic Sclerosis Drug introduction, etc. Systemic Sclerosis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Systemic Sclerosis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Systemic Sclerosis Drug Market Overview
1.1 Systemic Sclerosis Drug Product Overview
1.2 Systemic Sclerosis Drug Market Segment by Type
1.2.1 ARG-201
1.2.2 Belimumab
1.2.3 BL-1110
1.2.4 BOT-191
1.2.5 C-82
1.2.6 Others
1.3 Global Systemic Sclerosis Drug Market Size by Type
1.3.1 Global Systemic Sclerosis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Systemic Sclerosis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Systemic Sclerosis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Systemic Sclerosis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Systemic Sclerosis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Systemic Sclerosis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Systemic Sclerosis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Systemic Sclerosis Drug Sales Breakdown by Type (2018-2024)
2 Global Systemic Sclerosis Drug Market Competition by Company
2.1 Global Top Players by Systemic Sclerosis Drug Sales (2018-2024)
2.2 Global Top Players by Systemic Sclerosis Drug Revenue (2018-2024)
2.3 Global Top Players by Systemic Sclerosis Drug Price (2018-2024)
2.4 Global Top Manufacturers Systemic Sclerosis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Systemic Sclerosis Drug Market Competitive Situation and Trends
2.5.1 Systemic Sclerosis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Systemic Sclerosis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Systemic Sclerosis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Systemic Sclerosis Drug Market
2.8 Key Manufacturers Systemic Sclerosis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Systemic Sclerosis Drug Status and Outlook by Region
3.1 Global Systemic Sclerosis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Systemic Sclerosis Drug Historic Market Size by Region
3.2.1 Global Systemic Sclerosis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Systemic Sclerosis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Systemic Sclerosis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Systemic Sclerosis Drug Forecasted Market Size by Region
3.3.1 Global Systemic Sclerosis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Systemic Sclerosis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Systemic Sclerosis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Systemic Sclerosis Drug by Application
4.1 Systemic Sclerosis Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 ASCs
4.1.4 Others
4.2 Global Systemic Sclerosis Drug Market Size by Application
4.2.1 Global Systemic Sclerosis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Systemic Sclerosis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Systemic Sclerosis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Systemic Sclerosis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Systemic Sclerosis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Systemic Sclerosis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Systemic Sclerosis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Systemic Sclerosis Drug Sales Breakdown by Application (2018-2024)
5 North America Systemic Sclerosis Drug by Country
5.1 North America Systemic Sclerosis Drug Historic Market Size by Country
5.1.1 North America Systemic Sclerosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Systemic Sclerosis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Systemic Sclerosis Drug Sales in Value by Country (2018-2024)
5.2 North America Systemic Sclerosis Drug Forecasted Market Size by Country
5.2.1 North America Systemic Sclerosis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Systemic Sclerosis Drug Sales in Value by Country (2024-2034)
6 Europe Systemic Sclerosis Drug by Country
6.1 Europe Systemic Sclerosis Drug Historic Market Size by Country
6.1.1 Europe Systemic Sclerosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Systemic Sclerosis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Systemic Sclerosis Drug Sales in Value by Country (2018-2024)
6.2 Europe Systemic Sclerosis Drug Forecasted Market Size by Country
6.2.1 Europe Systemic Sclerosis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Systemic Sclerosis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Systemic Sclerosis Drug by Region
7.1 Asia-Pacific Systemic Sclerosis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Systemic Sclerosis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Systemic Sclerosis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Systemic Sclerosis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Systemic Sclerosis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Systemic Sclerosis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Systemic Sclerosis Drug Sales in Value by Region (2024-2034)
8 Latin America Systemic Sclerosis Drug by Country
8.1 Latin America Systemic Sclerosis Drug Historic Market Size by Country
8.1.1 Latin America Systemic Sclerosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Systemic Sclerosis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Systemic Sclerosis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Systemic Sclerosis Drug Forecasted Market Size by Country
8.2.1 Latin America Systemic Sclerosis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Systemic Sclerosis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Systemic Sclerosis Drug by Country
9.1 Middle East and Africa Systemic Sclerosis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Systemic Sclerosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Systemic Sclerosis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Systemic Sclerosis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Systemic Sclerosis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Systemic Sclerosis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Systemic Sclerosis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Allergan Plc
10.1.1 Allergan Plc Company Information
10.1.2 Allergan Plc Introduction and Business Overview
10.1.3 Allergan Plc Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Plc Systemic Sclerosis Drug Products Offered
10.1.5 Allergan Plc Recent Development
10.2 Angion Biomedica Corp.
10.2.1 Angion Biomedica Corp. Company Information
10.2.2 Angion Biomedica Corp. Introduction and Business Overview
10.2.3 Angion Biomedica Corp. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Angion Biomedica Corp. Systemic Sclerosis Drug Products Offered
10.2.5 Angion Biomedica Corp. Recent Development
10.3 arGentis Pharmaceuticals, LLC
10.3.1 arGentis Pharmaceuticals, LLC Company Information
10.3.2 arGentis Pharmaceuticals, LLC Introduction and Business Overview
10.3.3 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Products Offered
10.3.5 arGentis Pharmaceuticals, LLC Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Information
10.4.2 Bayer AG Introduction and Business Overview
10.4.3 Bayer AG Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bayer AG Systemic Sclerosis Drug Products Offered
10.4.5 Bayer AG Recent Development
10.5 BioLineRx, Ltd.
10.5.1 BioLineRx, Ltd. Company Information
10.5.2 BioLineRx, Ltd. Introduction and Business Overview
10.5.3 BioLineRx, Ltd. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 BioLineRx, Ltd. Systemic Sclerosis Drug Products Offered
10.5.5 BioLineRx, Ltd. Recent Development
10.6 BiOrion Technologies B.V.
10.6.1 BiOrion Technologies B.V. Company Information
10.6.2 BiOrion Technologies B.V. Introduction and Business Overview
10.6.3 BiOrion Technologies B.V. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 BiOrion Technologies B.V. Systemic Sclerosis Drug Products Offered
10.6.5 BiOrion Technologies B.V. Recent Development
10.7 Boehringer Ingelheim GmbH
10.7.1 Boehringer Ingelheim GmbH Company Information
10.7.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.7.3 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Products Offered
10.7.5 Boehringer Ingelheim GmbH Recent Development
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Company Information
10.8.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb Company Systemic Sclerosis Drug Products Offered
10.8.5 Bristol-Myers Squibb Company Recent Development
10.9 Corbus pharmaceuticals, Inc.
10.9.1 Corbus pharmaceuticals, Inc. Company Information
10.9.2 Corbus pharmaceuticals, Inc. Introduction and Business Overview
10.9.3 Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Products Offered
10.9.5 Corbus pharmaceuticals, Inc. Recent Development
10.10 CSL Limited
10.10.1 CSL Limited Company Information
10.10.2 CSL Limited Introduction and Business Overview
10.10.3 CSL Limited Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CSL Limited Systemic Sclerosis Drug Products Offered
10.10.5 CSL Limited Recent Development
10.11 Daval International Limited
10.11.1 Daval International Limited Company Information
10.11.2 Daval International Limited Introduction and Business Overview
10.11.3 Daval International Limited Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Daval International Limited Systemic Sclerosis Drug Products Offered
10.11.5 Daval International Limited Recent Development
10.12 Digna Biotech, S.L.
10.12.1 Digna Biotech, S.L. Company Information
10.12.2 Digna Biotech, S.L. Introduction and Business Overview
10.12.3 Digna Biotech, S.L. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Digna Biotech, S.L. Systemic Sclerosis Drug Products Offered
10.12.5 Digna Biotech, S.L. Recent Development
10.13 F. Hoffmann-La Roche Ltd.
10.13.1 F. Hoffmann-La Roche Ltd. Company Information
10.13.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.13.3 F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Products Offered
10.13.5 F. Hoffmann-La Roche Ltd. Recent Development
10.14 Fibrocell Science, Inc.
10.14.1 Fibrocell Science, Inc. Company Information
10.14.2 Fibrocell Science, Inc. Introduction and Business Overview
10.14.3 Fibrocell Science, Inc. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Fibrocell Science, Inc. Systemic Sclerosis Drug Products Offered
10.14.5 Fibrocell Science, Inc. Recent Development
10.15 GenKyoTex S.A.
10.15.1 GenKyoTex S.A. Company Information
10.15.2 GenKyoTex S.A. Introduction and Business Overview
10.15.3 GenKyoTex S.A. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 GenKyoTex S.A. Systemic Sclerosis Drug Products Offered
10.15.5 GenKyoTex S.A. Recent Development
10.16 GlaxoSmithKline Plc
10.16.1 GlaxoSmithKline Plc Company Information
10.16.2 GlaxoSmithKline Plc Introduction and Business Overview
10.16.3 GlaxoSmithKline Plc Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 GlaxoSmithKline Plc Systemic Sclerosis Drug Products Offered
10.16.5 GlaxoSmithKline Plc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Systemic Sclerosis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Systemic Sclerosis Drug Industrial Chain Analysis
11.4 Systemic Sclerosis Drug Market Dynamics
11.4.1 Systemic Sclerosis Drug Industry Trends
11.4.2 Systemic Sclerosis Drug Market Drivers
11.4.3 Systemic Sclerosis Drug Market Challenges
11.4.4 Systemic Sclerosis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Systemic Sclerosis Drug Distributors
12.3 Systemic Sclerosis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ARG-201
Table 2. Major Company of Belimumab
Table 3. Major Company of BL-1110
Table 4. Major Company of BOT-191
Table 5. Major Company of C-82
Table 6. Major Company of Others
Table 7. Global Systemic Sclerosis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Systemic Sclerosis Drug Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Systemic Sclerosis Drug Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Systemic Sclerosis Drug Sales by Type (2018-2024) & (US& Million)
Table 11. Global Systemic Sclerosis Drug Market Share in Value by Type (2018-2024)
Table 12. Global Systemic Sclerosis Drug Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Systemic Sclerosis Drug Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Systemic Sclerosis Drug Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Systemic Sclerosis Drug Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Systemic Sclerosis Drug Sales Market Share in Value by Type (2024-2034)
Table 17. Global Systemic Sclerosis Drug Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Systemic Sclerosis Drug Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Systemic Sclerosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Systemic Sclerosis Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Systemic Sclerosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Systemic Sclerosis Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Systemic Sclerosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Systemic Sclerosis Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Systemic Sclerosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Systemic Sclerosis Drug Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Systemic Sclerosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Systemic Sclerosis Drug Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Systemic Sclerosis Drug Sales Share by Company (2018-2024)
Table 30. Global Systemic Sclerosis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Systemic Sclerosis Drug Revenue Share by Company (2018-2024)
Table 32. Global Market Systemic Sclerosis Drug Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Systemic Sclerosis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Systemic Sclerosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Systemic Sclerosis Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into Systemic Sclerosis Drug Market
Table 37. Key Manufacturers Systemic Sclerosis Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Systemic Sclerosis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Systemic Sclerosis Drug Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Systemic Sclerosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Systemic Sclerosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Systemic Sclerosis Drug Sales Market Share in Value by Region (2018-2024)
Table 44. Global Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Systemic Sclerosis Drug Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Systemic Sclerosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Systemic Sclerosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Systemic Sclerosis Drug Sales Market Share in Value by Region (2024-2034)
Table 49. Global Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Systemic Sclerosis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Systemic Sclerosis Drug Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Systemic Sclerosis Drug Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Systemic Sclerosis Drug Sales Market Share in Value by Application (2018-2024)
Table 55. Global Systemic Sclerosis Drug Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Systemic Sclerosis Drug Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Systemic Sclerosis Drug Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Systemic Sclerosis Drug Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Systemic Sclerosis Drug Sales Market Share in Value by Application (2024-2034)
Table 60. Global Systemic Sclerosis Drug Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Systemic Sclerosis Drug Sales by Application (2018-2024) (K Pcs)
Table 62. North America Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Systemic Sclerosis Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Systemic Sclerosis Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Systemic Sclerosis Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Systemic Sclerosis Drug Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Systemic Sclerosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Systemic Sclerosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Systemic Sclerosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Systemic Sclerosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Systemic Sclerosis Drug Sales Market Share in Value by Country (2018-2024)
Table 75. North America Systemic Sclerosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Systemic Sclerosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Systemic Sclerosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Systemic Sclerosis Drug Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Systemic Sclerosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Systemic Sclerosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Systemic Sclerosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Systemic Sclerosis Drug Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Systemic Sclerosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Systemic Sclerosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Systemic Sclerosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Systemic Sclerosis Drug Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Systemic Sclerosis Drug Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Systemic Sclerosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Systemic Sclerosis Drug Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Systemic Sclerosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Systemic Sclerosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Systemic Sclerosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Systemic Sclerosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Systemic Sclerosis Drug Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Systemic Sclerosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Systemic Sclerosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Systemic Sclerosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Systemic Sclerosis Drug Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Systemic Sclerosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Systemic Sclerosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Systemic Sclerosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Systemic Sclerosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Value by Country (2024-2034)
Table 111. Allergan Plc Company Information
Table 112. Allergan Plc Introduction and Business Overview
Table 113. Allergan Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Allergan Plc Systemic Sclerosis Drug Product
Table 115. Allergan Plc Recent Development
Table 116. Angion Biomedica Corp. Company Information
Table 117. Angion Biomedica Corp. Introduction and Business Overview
Table 118. Angion Biomedica Corp. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Angion Biomedica Corp. Systemic Sclerosis Drug Product
Table 120. Angion Biomedica Corp. Recent Development
Table 121. arGentis Pharmaceuticals, LLC Company Information
Table 122. arGentis Pharmaceuticals, LLC Introduction and Business Overview
Table 123. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Product
Table 125. arGentis Pharmaceuticals, LLC Recent Development
Table 126. Bayer AG Company Information
Table 127. Bayer AG Introduction and Business Overview
Table 128. Bayer AG Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Bayer AG Systemic Sclerosis Drug Product
Table 130. Bayer AG Recent Development
Table 131. BioLineRx, Ltd. Company Information
Table 132. BioLineRx, Ltd. Introduction and Business Overview
Table 133. BioLineRx, Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. BioLineRx, Ltd. Systemic Sclerosis Drug Product
Table 135. BioLineRx, Ltd. Recent Development
Table 136. BiOrion Technologies B.V. Company Information
Table 137. BiOrion Technologies B.V. Introduction and Business Overview
Table 138. BiOrion Technologies B.V. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. BiOrion Technologies B.V. Systemic Sclerosis Drug Product
Table 140. BiOrion Technologies B.V. Recent Development
Table 141. Boehringer Ingelheim GmbH Company Information
Table 142. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 143. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Product
Table 145. Boehringer Ingelheim GmbH Recent Development
Table 146. Bristol-Myers Squibb Company Company Information
Table 147. Bristol-Myers Squibb Company Introduction and Business Overview
Table 148. Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. Bristol-Myers Squibb Company Systemic Sclerosis Drug Product
Table 150. Bristol-Myers Squibb Company Recent Development
Table 151. Corbus pharmaceuticals, Inc. Company Information
Table 152. Corbus pharmaceuticals, Inc. Introduction and Business Overview
Table 153. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Product
Table 155. Corbus pharmaceuticals, Inc. Recent Development
Table 156. CSL Limited Company Information
Table 157. CSL Limited Introduction and Business Overview
Table 158. CSL Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. CSL Limited Systemic Sclerosis Drug Product
Table 160. CSL Limited Recent Development
Table 161. Daval International Limited Company Information
Table 162. Daval International Limited Introduction and Business Overview
Table 163. Daval International Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. Daval International Limited Systemic Sclerosis Drug Product
Table 165. Daval International Limited Recent Development
Table 166. Digna Biotech, S.L. Company Information
Table 167. Digna Biotech, S.L. Introduction and Business Overview
Table 168. Digna Biotech, S.L. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 169. Digna Biotech, S.L. Systemic Sclerosis Drug Product
Table 170. Digna Biotech, S.L. Recent Development
Table 171. F. Hoffmann-La Roche Ltd. Company Information
Table 172. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 173. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 174. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Product
Table 175. F. Hoffmann-La Roche Ltd. Recent Development
Table 176. Fibrocell Science, Inc. Company Information
Table 177. Fibrocell Science, Inc. Introduction and Business Overview
Table 178. Fibrocell Science, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 179. Fibrocell Science, Inc. Systemic Sclerosis Drug Product
Table 180. Fibrocell Science, Inc. Recent Development
Table 181. GenKyoTex S.A. Company Information
Table 182. GenKyoTex S.A. Introduction and Business Overview
Table 183. GenKyoTex S.A. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 184. GenKyoTex S.A. Systemic Sclerosis Drug Product
Table 185. GenKyoTex S.A. Recent Development
Table 186. GlaxoSmithKline Plc Company Information
Table 187. GlaxoSmithKline Plc Introduction and Business Overview
Table 188. GlaxoSmithKline Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 189. GlaxoSmithKline Plc Systemic Sclerosis Drug Product
Table 190. GlaxoSmithKline Plc Recent Development
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Systemic Sclerosis Drug Market Trends
Table 194. Systemic Sclerosis Drug Market Drivers
Table 195. Systemic Sclerosis Drug Market Challenges
Table 196. Systemic Sclerosis Drug Market Restraints
Table 197. Systemic Sclerosis Drug Distributors List
Table 198. Systemic Sclerosis Drug Downstream Customers
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Systemic Sclerosis Drug Product Picture
Figure 2. Global Systemic Sclerosis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Systemic Sclerosis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Systemic Sclerosis Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ARG-201
Figure 6. Global ARG-201 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Belimumab
Figure 8. Global Belimumab Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of BL-1110
Figure 10. Global BL-1110 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of BOT-191
Figure 12. Global BOT-191 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of C-82
Figure 14. Global C-82 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Systemic Sclerosis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Systemic Sclerosis Drug Sales Market Share by Type in 2022 & 2034
Figure 19. North America Systemic Sclerosis Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America Systemic Sclerosis Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe Systemic Sclerosis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe Systemic Sclerosis Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America Systemic Sclerosis Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Systemic Sclerosis Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Systemic Sclerosis Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Systemic Sclerosis Drug Revenue in 2022
Figure 31. Systemic Sclerosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of ASCs
Figure 37. Global ASCs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Systemic Sclerosis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Systemic Sclerosis Drug Sales Market Share by Application in 2022 & 2034
Figure 42. North America Systemic Sclerosis Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Systemic Sclerosis Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Systemic Sclerosis Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Systemic Sclerosis Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Systemic Sclerosis Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Systemic Sclerosis Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Systemic Sclerosis Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Systemic Sclerosis Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Systemic Sclerosis Drug Manufacturing Cost Structure
Figure 53. Systemic Sclerosis Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries